Differentiating Asymptomatic Bacteriuria From Urinary Tract Infection in the Pediatric Neurogenic Bladder Population: NGAL As a Promising Biomarker.
Gupta. Sudipti S; Preece. Janae J; Haynes. Andria A; Becknell. Brian B; Ching. Christina C
Key Findings
- NGAL levels were significantly higher in urinary tract infections (UTI) compared to asymptomatic bacteriuria (ASB) in pediatric neurogenic bladder patients.
- NGAL showed 82.4% sensitivity and 83.3% specificity for distinguishing UTI from ASB.
- All five urinary antimicrobial peptides, including LL-37, were elevated in neurogenic bladder patients versus healthy controls.
Practical Outcomes
- For biohackers monitoring urinary health, NGAL could become a useful biomarker to differentiate an actual infection from harmless bacteria, potentially guiding when to treat with antibiotics. However, the findings are specific to children with neurogenic bladders, so broader applicability remains uncertain.
Summary
Researchers measured several antimicrobial peptides in the urine of kids with neurogenic bladders and found that one of them, NGAL, was higher in true infections than in harmless bacterial presence, making it a possible test to tell the two apart.
Abstract
<b>Objective:</b> To evaluate whether urinary antimicrobial peptides (AMPs) can discriminate between asymptomatic bacteriuria (ASB) and urinary tract infection (UTI) in pediatric patients with neurogenic bladder (NGB). <b>Design/Methods:</b> Bladder urine was collected from pediatric patients (≤18 years old) with NGB without augmentation cystoplasty. Patients were divided into the following groups based on symptomatology and results of urinalysis/urine culture: (a) UTI, (b) ASB, and (c) sterile. Urine AMPs β defense 1 (BD-1), neutrophil gelatinase-associated lipocalin (NGAL), cathelicidin (LL-37), hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein (HIP/PAP), and human α defensin 5 (HD-5) were compared between groups by enzyme-linked immunosorbent assays. In addition, urines from pediatric controls without NGB or UTI were also analyzed. Significance was determined using Student's <i>t</i> test for parametric or Mann-Whitney <i>U</i> test for nonparametric data. A <i>p</i> value of <.05 was considered significant. <b>Results:</b> Thirty-six patients with NGB from a spinal dysraphism were evaluated: UTI, <i>n</i> = 6; ASB, <i>n</i> = 18; sterile, <i>n</i> = 12. These groups did not differ significantly by age but did significantly differ by gender (<i>p</i> = .0139). NGAL significantly differed between UTI and ASB groups (median 38.5 ng/mg vs 15.5 ng/mg, respectively; <i>p</i> = .0197) with a sensitivity and specificity of 82.4% and 83.3%, respectively. HIP/PAP, BD-1, HD-5, LL-37, and NGAL levels were all significantly higher in sterile NGB urines compared to 17 non-NGB pediatric controls (<i>p</i> < .0001, <i>p</i> = .0020, <i>p</i> = .0035, <i>p</i> = .0006, and <i>p</i> = .0339, respectively). <b>Conclusion:</b> All five urinary AMPs evaluated were significantly elevated in NGB patients compared to controls. NGAL levels may help differentiate between UTI and ASB in pediatric NGB patients.
Study Information
pubmed
2019
2019-06-01T00:00:00.000Z
10.1310/sci2503-214
11
51